ライフプランニングセンターにおける『新老人』の身体的健康特性に関する検討―第5次循環器疾患基礎調査(2000)との比較をもとにして―

書誌事項

タイトル別名
  • Comparative Studies on the Physical Health Characteristics of New Elder Citizens at the Life Planning and the Elderly Subjects Recruited in the Fifth National Survey of Cardiovascular Diseases (2000)

この論文をさがす

抄録

Background: Morphological and functional standards for the health evaluation of the elderly has not ever been established in our country. The health status of the cohort that might be served for this purpose has to be clearly specified. Study purposes: Comparisons of comorbidity and related risk factors of cardiovascular disorders were performed between two groups; health research volunteers (HRV) among New Elder Citizens at the Life Planning Center and subjects (GN) recruited in the Fifth National Survey of Cardiovascular Diseases (2000) . Subjects and Methods: All subjects were above the age of 70 years. HRV and GN groups consisted of 132 males and 122 females, and 635 males and 896 females, respectively. Selected cardiovascular disorders and related risk factors were as follows; stroke, myocardial infarction, angina pectoris, diabetes mellitus, hypercholesterolemia and smoking. Results: Prevalences of stroke, myocardial infarction, angina pectoris, diabetes mellitus and hypertension were significantly higher in GN than in HRV cohorts in both sexes. On the other hand, hypercholesterolemia was significantly more frequent in HRV than in GN, and more over, females revealed higher prevalence than males did in both cohorts. Surprisingly enough, prevalence of smokers were extremely low in males of HRV (4.5%) comparing in those of GN (29.5%) cohorts. Conclusions: In general, the health status with regard to cardiovascular disorders is thought to be more ideal in HRV than in GN cohorts in both sexes, and HRV cohort might be suitable candidate for giving morphological and functional standards of the elderly with regard to physical health assessment.

収録刊行物

  • 総合健診

    総合健診 31 (3), 469-475, 2004

    一般社団法人 日本総合健診医学会

参考文献 (11)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ